Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus Radiotherapy for Pediatric Neuroblastoma
NCT02615106Phase 2Unknown
- Sponsor
- Xinhua Hospital
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in neuroblastoma, sponsored by Xinhua Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT02615106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615106.